The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSTN.L Regulatory News (HSTN)

  • There is currently no data for HSTN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Hansteen Holdings PLC

17 Jan 2020 12:00

RNS Number : 1497A
Peel Hunt LLP
17 January 2020
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Hansteen Holdings Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Hansteen Holdings Plc

(d) Date dealing undertaken:

16 January 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

19,235

116.22 GBx

116.22 GBx

Ordinary Shares

Sell

75,000

116.60 GBx

116.40 GBx

 

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

17 January 2020

 

Contact name:

Alec Whitelaw

Telephone number:

0207 418 8860

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFIFEDLDIDLII
Date   Source Headline
15th Dec 20173:49 pmRNSHolding(s) in Company
30th Nov 20174:18 pmRNSReplacement - Director/PDMR Shareholding
30th Nov 20172:53 pmRNSTotal Voting Rights
24th Nov 20174:15 pmRNSHolding(s) in Company
23rd Nov 20173:37 pmRNSHolding(s) in Company
22nd Nov 201711:29 amRNSHolding(s) in Company
16th Nov 20175:40 pmRNSHolding(s) in Company
16th Nov 20175:30 pmRNSHolding(s) in Company
10th Nov 20171:21 pmRNSBOARD CHANGES
9th Nov 20173:31 pmRNSHolding(s) in Company
9th Nov 201712:46 pmRNSHolding(s) in Company
9th Nov 201710:34 amRNSHolding(s) in Company
8th Nov 20174:25 pmRNSDirector/PDMR Shareholding
8th Nov 20177:00 amRNSPURCHASE OF TENDER OFFER SHARES
6th Nov 20174:05 pmRNSResult of Tender Offer
3rd Nov 201712:30 pmRNSHolding(s) in Company
1st Nov 20172:04 pmRNSHolding(s) in Company
26th Oct 20177:00 amRNSResult of General Meeting
23rd Oct 20171:36 pmRNSHolding(s) in Company
17th Oct 20176:06 pmRNSTransaction in Own Shares
17th Oct 20174:39 pmRNSDirector/PDMR Shareholding
9th Oct 20173:48 pmRNSTransaction in Own Shares
9th Oct 20179:53 amRNSHolding(s) in Company
4th Oct 20177:00 amRNSTENDER OFFER & NOTICE OF GENERAL MEETING
25th Sep 20177:00 amRNSAcquisition of four industrial estates for £26m
4th Sep 20177:35 amRNSTotal Voting Rights
4th Sep 20177:30 amRNSTransaction in Own Shares
30th Aug 20177:30 amRNSHansteen completes £7.06 million disposal
23rd Aug 20177:00 amRNSHalf-year Report
17th Aug 20178:43 amRNSHolding(s) in Company
17th Aug 20178:39 amRNSHolding(s) in Company
16th Aug 20174:53 pmRNSHolding(s) in Company
15th Aug 20175:09 pmRNSHolding(s) in Company
10th Aug 201712:05 pmRNSHolding(s) in Company
7th Aug 20174:03 pmRNSHolding(s) in Company
4th Aug 201712:26 pmRNSHolding(s) in Company
2nd Aug 20178:00 amRNSNotice of Results
31st Jul 20178:00 amRNSTotal Voting Rights
19th Jul 20174:46 pmRNSHolding(s) in Company
12th Jul 20173:48 pmRNSHolding(s) in Company
11th Jul 20174:37 pmRNSHolding(s) in Company
10th Jul 20175:12 pmRNSTotal Voting Rights
3rd Jul 201710:05 amRNSEmployee Benefit Trust Share Purchase
29th Jun 20175:23 pmRNSHolding(s) in Company
29th Jun 20175:17 pmRNSHolding(s) in Company
29th Jun 20175:02 pmRNSFurther re Convertible Bonds due 2018
26th Jun 20175:11 pmRNSRe Convertible Bonds due 2018
23rd Jun 20175:43 pmRNSSqueeze out of outstanding IMPT shares
19th Jun 20177:00 amRNSCompletion of 1.28 Billion Euro Disposal
13th Jun 20173:49 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.